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Kallikrein Expression and Cathelicidin Processing
Are Independently Controlled in Keratinocytes by
Calcium, Vitamin D3, and Retinoic Acid
Shin Morizane1,2, Kenshi Yamasaki1,2, Filamer D. Kabigting1,2 and Richard L. Gallo1,2
Cathelicidin has dual functions in the skin, acting as an innate antibiotic and as an immunomodulator in
diseases such as rosacea and psoriasis. The serine proteases kallikrein 5 (KLK5) and kallikrein 7 (KLK7) control
enzymatic processing of cathelicidin precursor in the skin and regulate the eventual function of the final forms
of these peptides. We analyzed factors that control expression of KLK5 and KLK7 in normal human epidermal
keratinocytes to better understand how these may influence cathelicidin processing and function. Increased
extracellular calcium-induced KLK5 and KLK7 mRNA expression and protein release in a time-dependent
manner that is similar to induction of differentiation markers such as keratin 10 and involucrin. However,
1,25(OH)2 vitamin D3, 9-cis retinoic acid (RA), and 13-cis RA also induced the KLKs, but the timing and pattern of
KLK induction for each were different and distinct from changes in differentiation markers. Increased protease
activity and differential processing of cathelicidin accompanied increased KLK expression. These findings show
that the expression and activity of KLK are under fine control and can be distinctly influenced by variables such
as differentiation, calcium, vitamin D, and RA. Thus, these variables may further control the functions of
antimicrobial peptides in the skin.
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INTRODUCTION
Cathelicidin is one of several antimicrobial peptides in
mammals and is best known for its capacity to protect
against infection by microbial pathogens in skin and other
organ systems (Zanetti et al., 2002). Peptides derived from
the cathelicidin gene Camp have an integral role in innate
immunity by directly killing pathogenic microorganisms
such as Gram-positive (Nizet et al., 2001) and Gram-negative
bacteria (Rosenberger et al., 2004; Iimura et al., 2005), fungi
(Lopez-Garcia et al., 2005) as well as some viruses (Howell
et al., 2004). LL-37, the carboxy-terminal peptide fragment
derived from the human cathelicidin precursor protein
hCAP18, not only has the capacity to kill a wide variety
of microbes, but also can modify host immune and growth
responses (Lai and Gallo, 2009). These host responses to
LL-37 are complex and dependent on the system evaluated.
Observations for LL-37 action have included those showing
proinflammatory activity (Braff et al., 2005b; Yamasaki
et al., 2007), anti-inflammatory activity (Mookherjee et al.,
2006a, b; Morioka et al., 2008), promoting chemotaxis
(De et al., 2000) and angiogenesis (Koczulla et al., 2003),
and enhancing wound repair (Tokumaru et al., 2005). Owing
to these and other functions, LL-37 has been implicated
in a wide variety of inflammatory skin diseases including
psoriasis, atopic dermatitis, and rosacea (Ong et al., 2002;
Lande et al., 2007; Yamasaki et al., 2007). Importantly, the
activity of cathelicidin in humans is controlled by enzymatic
processing to LL-37 or smaller peptides. Recently, our group
showed that serine proteases kallikrein 5 (KLK5) and
kallikrein 7 (KLK7) participate in the enzymatic processing
of hCAP18 in the skin (Yamasaki et al., 2006).
Human tissue KLKs consist of 15 trypsin-like or chymo-
trypsin-like secreted serine proteases and their genes form a
cluster at the telomeres of the long arm of chromosome 19, in
the cytogenic region q13.3– 4 (Lundwall and Brattsand,
2008). In the skin, KLK5 and KLK7, known as the major serine
proteases, degrade corneodesmosome proteins, leading to
desquamation (Caubet et al., 2004; Lundwall and Brattsand,
2008). Aberrant KLK expression or function has been reported
to be involved in skin diseases such as Netherton syndrome
and rosacea (Descargues et al., 2005; Yamasaki et al., 2007).
Overexpression of human KLK7 in mouse epidermis results in
chronic itchy dermatitis (Hansson et al., 2002).
Despite the importance of KLKs to multiple biological
processes, the regulation of KLK has been incompletely
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studied. Expression in some cell lines, such as a prostate
carcinoma cell line LNCaP and a breast carcinoma cell line
BT-474, has been reported, but the factors that regulate KLK5
and KLK7 expression in keratinocytes remain largely un-
known (Yousef and Diamandis, 2001; Shaw and Diamandis,
2008). Therefore, we studied here several factors that
influence keratinocyte function to examine how these might
influence KLK expression and eventual processing of
cathelicidin. Our findings suggest that Ca2þ , 1,25(OH)2
vitamin D3 (1,25(OH)2VD3), and retinoic acid (RA) can
modulate innate antimicrobial peptide function in the
epidermis through modulation of the final balance of KLK
enzymatic activity in the skin.
RESULTS
KLK 5 and 7 expression is inducible in epidermal keratinocytes
during differentiation
To analyze the regulation of KLK5 and KLK7 expression in
keratinocytes, an array of potential stimuli for keratinocytes
was examined, including hormones, biological stimuli,
cytokines, growth factors, and microbial products. Of these
stimuli, we found that increased Ca2þ in the medium to
2mM, 1,25(OH)2VD3, 9-cis RA, and 13-cis RA each
increased KLK5 and KLK7 mRNA expression in cultured
normal human epidermal keratinocytes (NHEKs) (Figure 1). It
is interesting to observe that several molecules with potent
effects on keratinocyte growth or cytokine release, including
dexamethasone, epidermal growth factor, poly(I:C), and
MALP-2, had little effect on KLK gene expression.
KLK5 and KLK7 are constitutively expressed in greatest
abundance in the granular layer of the epidermis, (Ekholm
and Egelrud, 2000). To partially induce this phenotype,
keratinocytes have been cultured in high concentrations of
Ca2þ , a manipulation that is known to induce differentiation
of keratinocytes and thought to mimic the Ca2þ gradient
observed in normal skin (Mauro et al., 1998). We therefore
examined if the increase observed in KLK5 and KLK7 that is
induced by increasing the concentration of Ca2þ in the
culture medium also induces markers of differentiation in
parallel, or if the acquisition of a differentiated phenotype
could be distinguished from induction of KLK expression.
NHEKs in basal growth conditions at 30% confluence were
stimulated with 2mM Ca2þ for various times and quantitative
real-time-PCR performed to analyze the time course of KLK5
and KLK7 mRNA expression. Ca2þ induced KLK5 and KLK7
mRNA expression in keratinocytes after 24 hours, and the
increase in KLK7 mRNA (10,000-fold at 96 hours) was greater
than that in KLK5 (25-fold at 96 hours) (Figure 2a and b). It is
noted, however, that the basal expression of KLK5 mRNA was
abundant, whereas that of KLK7 was very low in non-
stimulated conditions. Thus, after Ca2þ stimulation, although
the relative expression of the KLK7 gene was exponentially
increased, this does not imply a greater expression of KLK7.
Consistent with these observations, protein abundance for
KLK5 and KLK7 increased after elevated Ca2þ in a time-
dependent manner, and the total amount of KLK7 remained
less than KLK5 (Figure 2c and d). Analysis of the timing for
expression of keratin 10 (KRT10) and involucrin (IVL)
mRNAs, evaluated as markers of differentiation for epidermal
keratinocytes, showed that NHEKs cultured in high-concen-
tration Ca2þ had higher KRT10 expression than those in
basal media, and this pattern was similar to that of KLK7
expression (Figure 2e and g). Induction of IVL, similar to
KLK5, was also dependent on the presence of high
concentration of Ca2þ in media and occurred over a similar
time as KLK5 and KLK7 (Figure 2f and h).
1,25(OH)2VD3 increases KLK expression independently of
differentiation
We next examined the kinetics of KLK5, KLK7, KRT10, and IVL
expression when keratinocytes were cultured in the presence
of 1,25(OH)2VD3, a culture condition that can also influence
keratinocyte differentiation, but in a manner different from
Ca2þ (Bikle, 2004). As in the growth conditions tested with
Ca2þ , NHEKs at 30% confluence were stimulated with
1,25(OH)2VD3 for various times. A peak increase in KLK5
and KLK7 mRNA expression was observed at 24 hours after
1,25(OH)2VD3 addition, which gradually decreased afterward
(Figure 3a and b). 1,25(OH)2VD3 induced KLK5 and KLK7 in a
dose-dependent manner between 10–9M (1nM) and 10–7M
(100nM) (Figure 3c and d). KLK5 and KLK7 protein in the
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Figure 1. Regulation of KLK5 and KLK7 mRNA expression in keratinocytes.
NHEKs (passage 7) at 80% confluence were stimulated with hormones,
biological stimuli, cytokines, growth factors, and microbial products for
24 hours. The concentration used for each stimulus is shown in Materials
and Methods. The expression of KLK5 and KLK7 mRNA was measured by
quantitative real-time PCR. mRNA expression was calculated as relative to
GAPDH mRNA, and all data are presented as fold change against vehicle-
treated control. Data represent the mean±SEM of triplicate determinations
from a single experiment representative of three independent experiments.
**Po0.01, ***Po0.001.
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media were both induced by 1,25(OH)2VD3 in a time-
dependent manner (Figure 3e and f). Similar to Ca2þ
stimulation, the relative increase in KLK7 protein was greater
than that for KLK5 protein. However, in contrast to the
induction of KRT10 and IVL expression by Ca2þ ,
1,25(OH)2VD3 suppressed KRT10 mRNA expression in NHEKs
at 30% confluence (Figure 3g), and IVL mRNA expression was
not affected under the conditions observed for induction of the
KLKs (Figure 3h). Protein levels of KRT10 and IVL showed a
similar trend to mRNA expression (Figure 3i and j). Thus,
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Figure 2. High Ca2þ induces KLK5 and KLK7 expression in keratinocytes. NHEKs (passage 5) initially at 30% confluence were cultured in the presence of
0.06mM (control) or 2mM Ca2þ for 3, 6, 12, 24, 48, 72, or 96 hours. The expression of KLK5 (a), KLK7 (b), KRT10 (e), and IVL (f) mRNA were measured
by quantitative real-time PCR. KLK5 (c) and KLK7 (d) protein in media was measured by ELISA. mRNA expression was calculated as relative to
GAPDH mRNA, and all data are presented as fold increase against 0 hour non-treated control. (g, h) KRT10 and IVL protein expression was examined in NHEKs
(passage 6) cultured in 2mM Ca2þ for 24 or 48 hours by In-Cell Western as described in Materials and Methods. The percent responses were calculated against
vehicle-treated control at each time point. Data represent the mean±SEM of triplicate determinations from a single experiment representative of three
independent experiments. *Po0.05, **Po0.01.
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Figure 3. 1,25(OH)2VD3 induces KLK5 and KLK7 expression in keratinocytes.NHEKs (passage 5) initially at 30% confluence were stimulated with 1,25(OH)2VD3 (10
–7 M)
or the vehicle for 3, 6, 12, 24, 48, 72, or 96 hours. The expression of KLK5 (a), KLK7 (b), KRT10 (g), and IVL (h) mRNA was measured by quantitative real-time PCR (qPCR).
(c, d) NHEKs (passage 5) were stimulated with 10–9 to 10–7M of 1,25(OH)2VD3 for 24 hours, and the expression of KLK5 (c) and KLK7 (d) mRNA was measured by qPCR.
mRNA expression was calculated as the relative expression to GAPDHmRNA, and all data are presented as fold increase against control. KLK5 (e) and KLK7 (f) protein in
the culture media was measured by ELISA. (i, j) NHEKs (passage 6) were stimulated with 10–9 or 10–7M of 1,25(OH)2VD3 for 24 or 48 hours, and KRT10 and IVL protein
expression was examined by In-Cell Western as described in Materials and Methods. The percent responses were calculated against vehicle-treated control at each
time point. Data represent the mean±SEM of triplicate determinations from a single experiment representative of three independent experiments. **Po0.01, ***Po0.001.
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unlike Ca2þ , 1,25(OH)2VD3 can increase the expression and
release of KLK5 and KLK7 from keratinocytes in a manner that
is not dependent on induction of differentiation markers KRT10
and IVL.
KLK and cathelicidin colocalizes in keratinocytes stimulated
with 1,25(OH)2VD3
1,25(OH)2VD3 is also known to greatly induce cathelicidin
expression in keratinocytes (Schauber et al., 2006). Next, to
further confirm results of Figure 3 and to determine the
relative localization of KLK5 and cathelicidin in keratinocytes
stimulated with 1,25(OH)2VD3, immunostaining for KLK5
and cathelicidin was performed. Enhanced expression of
both KLK5 and cathelicidin protein was observed in NHEKs
stimulated with 1,25(OH)2VD3, and these antigens were
colocalized in a peri-nuclear pattern consistent with ER or
cis-Golgi (Figure 4). This pattern of expression was consistent
with previous reports of basal expression of KLK7 and KLK5
in lamellar granules (Ishida-Yamamoto et al., 2005), and the
expression of cathelicidin also matched that previously
reported (Braff et al., 2005a). These data therefore support
the conclusion that the localization of KLK7 in NHEKs
stimulated with 1,25(OH)2VD3 was similar to KLK5, and both
colocalize with cathelicidin.
RAs increase KLK expression independently of keratinocyte
differentiation
RA is known to modulate keratinocyte differentiation, and it
has been reported that all-trans RA upregulates IVL expres-
sion but downregulates KRT10 expression (Poumay et al.,
1999). We therefore examined the kinetics of KLK5, KLK7,
KRT10, and IVL expression by RA in keratinocytes to further
establish that KLK expression can be regulated independently
of differentiation. Both 9-cis RA and 13-cis RA increased
KLK5 and KLK7 mRNA expression with the peak at 72 hours
(Figure 5a and b). Both 9-cis RA and 13-cis RA induced
KLK5 and KLK7 in a dose-dependent manner between 10–9 M
(1 nM) and 10–7 M (100 nM) (Figure 5c and d). Similar to
1,25(OH)2VD3, both 9-cis RA and 13-cis RA also increased
KLK5 and KLK7 protein in the media (Figure 5e and f). In
contrast, both 9-cis RA and 13-cis RA decreased KRT10
mRNA expression compared with the control in NHEKs at
30% confluence (Figure 5g), consistent with the previous
reports (Poumay et al., 1999). IVL mRNA expression was not
significantly changed by RA (Figure 5h). Therefore, similar to
the observations with 1,25(OH)2VD3, KLK5 and KLK7 could
be induced in cultured keratinocytes without inducing an
increase in IVL and in a relative kinetic pattern different from
the induction of KRT10.
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Increasing KLK expression promotes differential processing of
cathelicidin in keratinocytes
Next, we analyzed whether the increase in KLK expression
could affect the protease activity of keratinocytes and final
capacity to process endogenous cathelicidin precursor
protein. Protease activity was significantly increased by
culturing in 2mM Ca2þ (Figure 6a), a finding consistent with
earlier findings of an increase in mRNA and protein
abundance. Importantly, 1,25(OH)2VD3 and RA had an
additive effect on protease activity in high calcium conditions
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Figure 5. Retinoic acids induce KLK5 and KLK7 expression in keratinocytes. NHEKs (passage 3) initially at 30% confluence were stimulated with 9-cis RA
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(Figure 6a). We also observed an increase in protease activity
in the culture media of cells maintained in 0.06mM calcium
and then treated with 1,25(OH)2VD3 or RA, although the
increase was not as large as that observed in NHEKs cultured
in 2mM calcium media (data not shown).
To examine whether the increase in protease activity by
these stimuli could modify the processing of cathelicidin,
active cathelicidin peptides in NHEKs were analyzed by
surface-enhanced laser desorption/ionization time-of-flight
mass spectrometry (SELDI-TOF-MS). To examine the intrinsic
cathelicidin processing by calcium gradient, we cultured
NHEKs in 1mM calcium because (1) cathelicidin is gradually
synthesized by calcium gradient, and culturing NHEKs in 1-
mM calcium media is more efficient to induce cathelicidin
than in 2-mM calcium media (data not shown), (2) 1mM and
2mM calcium has a similar effect on KLK induction in 48
hours (data not shown). 1,25(OH)2VD3 is a primary factor of
cathelicidin induction in NHEKs (Schauber et al., 2006), and
we detected intrinsic cathelicidin processing. RAs, however,
barely induce cathelicidin (Schauber et al., 2006), and we
could not observe the cathelicidin processing in this assay.
The mass of cathelicidin peptides that was detected in the
Ca2þ -stimulated or 1,25(OH)2VD3-stimulated NHEKs was
different from each other but both were abundantly detected
compared with the lack of detectable processed peptides in
non-treated NHEKs (Figure 6b). Thus, induction of KLKs
correlated with the appearance of processed cathelicidin
peptides, but the mass distribution of these peptides was
dependent on the nature of the stimulus used to increase KLK
expression.
DISCUSSION
Recent progress in understanding elements of the epidermis
that participate in defense against pathogenic micro-
organisms has identified antimicrobial peptides such as
cathelicidins and b-defensins as peptides that have an
important role in preventing infection and modulating
inflammation in the skin (Schauber and Gallo, 2008). These
and other antimicrobial molecules form a chemical shield that
works with the physical barrier of the stratum corneum. KLK5
and KLK7, enzymes known for their role in controlling the
physical barrier of the stratum corneum (Eissa and Diamandis,
2008), have now been shown to also influence the capacity of
cathelicidin to be activated to peptide forms that can provide
an antimicrobial barrier. Therefore, the combination of effects
by KLK5 and KLK7 on skin barrier defense makes the
understanding of the systems that control these genes
important. To our best knowledge, it is previously unreported
that the regulation of KLK5 and KLK7 expression in keratino-
cytes is influenced by several factors that can also influence
epidermal differentiation. These observations uncover the
existence of an important but distinct regulatory system that
influences cutaneous innate immunity.
KLK5 and KLK7 are constitutively expressed in the skin and
are abundant in the granular layer, an observation that appeared
to link their expression to differentiation (Ekholm and Egelrud,
2000). In this study, we have shown that increasing extracellular
Ca2þ induced KLK5 and KLK7 expression, and that this
manipulation also increased the expression of differentiation
markers such as KRT10 and IVL. KLK7 has been previously
reported to be induced at a transcriptional level by Ca2þ -
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induced differentiation (Seo et al., 2004), but we show now that
KLK5 and KLK7 are both induced by high-concentration Ca2þ
and confirm that this increase in transcript is accompanied by
increased KLK protein and enzyme activity. The increase in
KLK5 or KLK7 expression by Ca2þ was similar to that of IVL or
KRT10 expression. These findings suggest that Ca2þ itself or the
state of Ca2þ -induced differentiation in keratinocytes will
influence expression and activity of KLKs.
Several factors that activate keratinocyte growth and immune
function were shown from the data of Figure 1 to have relatively
little effect on KLK expression. However, we found here that
1,25(OH)2VD3, a relatively recently recognized important
modulator of immune status (Bikle, 2008), will induce KLK5
and KLK7 in keratinocytes. Unexpectedly, 1,25(OH)2VD3
suppressed KRT10 mRNA expression in NHEKs and also had
little effect on IVL. These time course experiments were begun at
30% confluence to avoid the initial influence of spontaneous
differentiation when they reach confluence. As variable
differentiation responses to 1,25(OH)2VD3 have been previously
observed, it is conceivable that 1,25(OH)2VD3 might differently
affect KRT10 and IVL expression depending on confluence. At
later time points, the 1,25(OH)2VD3 added to culture medium at
the start of the experiment may no longer be active, or vitamin D
receptor expression registered a decrease. Either or both
processes are one of several explanations for the drop in KLK5
and KLK7 expression observed after 24 hours. Clearly, however,
these results further show that 1,25(OH)2VD3 regulates the
expression of KLKs independently from the expression of these
differentiation markers. In addition, through the coincident
induction of cathelicidin by 1,25(OH)2VD3, it could be
observed that the increased KLK5 colocalized with increased
cathelicidin, an observation that predicted that the cathelicidin
precursor protein hCAP18 (18kDa in mass) would be observed
to be processed into smaller peptide forms between 4 and 5kDa
as observed in Figure 6b.
In addition, but distinctly from 1,25(OH)2VD3, both 9-cis RA
and 13-cis RA also induced KLK5 and KLK7 expression, and this
was also observed to occur independently of differentiation. 9-
cis RA is known to bind to both RA receptors (RARs) and
retinoid X receptors (RXRs) (Nagpal and Chandraratna, 2000).
13-cis RA does not bind to RARs and RXRs with high affinity, but
rather is metabolized in the cell into other isomers including all-
trans RA and 9-cis RA (Allenby et al., 1993; Agarwal et al.,
1996; Blaner, 2001). RXRs form RXR homodimers and
RAR–RXR heterodimers or can heterodimerize with other
nuclear receptors, including the vitamin D receptor (Nagpal
and Chandraratna, 2000). These receptors induce transcription
by binding to response elements such as RA response element,
retinoid X response element, and vitamin D response element.
The human KLK10 promoter has been reported to have an RA
response element and retinoid X response element in some
studies (Zeng et al., 2006). Analysis of the human KLK5 and
KLK7 promoters using the MatInspector program did not
comment on these RA response element and retinoid X response
element sites (Dong et al., 2008), and neither did this program
predict the vitamin D response/RXR element in the cathelicidin
promoter region, in which a functional vitamin D response/RXR
element in keratinocytes has been confirmed for the cathelicidin
gene CAMP (Schauber et al., 2006). Despite this, a manual
search of KLK5 and KLK7 50UTR reveals several possible RXR/
RAR-binding sites that require future analysis and confirmation.
Such further analyses will enable better understanding of the
mechanism of transcriptional and post-transcriptional regulation
of KLK5 and KLK7.
Importantly, to our best knowledge, it is previously
unreported that the increase in KLK expression in keratinocytes
occurs in parallel to an increase in protease activity and in
enzymatic processing of cathelicidin. Additional analysis will
be necessary to report with confidence the exact mass and
sequence of cathelicidin peptides produced by keratinocytes
stimulated with 1,25(OH)2VD3 or Ca
2þ . However, it is
apparent that extracts from NHEKs stimulated with high-
concentration Ca2þ showed different peptides than that of
1,25(OH)2VD3-stimulated NHEKs. Furthermore, peptides sig-
nificantly smaller than the mass predicted for the best known
human cathelicidin peptide (LL-37) were observed in NHEKs
stimulated with 1,25(OH)2VD3. Complete understanding of the
proteolytic balance necessary for predicting the steady-state
peptide product is difficult and must also include an under-
standing of the action of endogenous protease inhibitors.
Furthermore, KLKs are also known to require their own
enzymatic processing for activation. Pro-KLK7 can be activated
by KLK5, other serine proteases, and metalloproteases;
however, the activation of pro-KLK5 is not fully understood
(Borgono and Diamandis, 2004). As a Ca2þ gradient is
observed in normal epidermis with the maximum concentra-
tion in the granular layer (Mauro et al., 1998), the present result
might explain why cathelicidin peptides are more abundant in
upper layers of the epidermis, which are more important for
defense against pathogenic microbes, than basal layers that
may be more important in communication to other elements of
the skin immune system.
In summary, we show here that Ca2þ , 1,25(OH)2VD3, and
RA will each induce the processing enzymes of cathelicidin,
KLKs, in keratinocytes. Further studies to understand the
significance of the effect of these systems on KLK activation
may clarify the clinical effects of these compounds on skin
barrier function and lead to unique applications relevant to
the manipulation of cutaneous innate immunity.
MATERIALS AND METHODS
Cell culture and stimuli
NHEKs were obtained from Cascade Biologics/Invitrogen. (catalog
number: C-001-5C, Portland, OR), and grown in serum-free EpiLife
cell culture media (Cascade Biologics/Invitrogen) containing
0.06mM Ca2þ and 1 EpiLife Defined Growth Supplement (EDGS,
Cascade Biologics/Invitrogen) at 37 1C under standard tissue culture
conditions. Cultures were maintained for up to eight passages in this
media with the addition of 100Uml–1 penicillin and 50 mgml–1
streptomycin. Cells were stimulated with 1,25(OH)2VD3 (100 nM;
Sigma-Aldrich, St Louis, MO), 9-cis RA (100 nM; Sigma-Aldrich),
13-cis RA (100 nM; Sigma-Aldrich), dexamethasone, (1mM; Sigma-
Aldrich), 17b-estradiol (100 nM; Sigma-Aldrich) Ca2þ (2mM), epi-
dermal growth factor (20 ngml–1; R&D Systems, Minneapolis, MN),
tumor necrosis factor-a (20 ngml–1; Chemicon, Temecula, CA),
IFN-a(200Uml–1, Chemicon), transforming growth factor b1 (10ngml
–1,
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R&D Systems), IL-6 (50ngml–1; R&D Systems), IL-8 (50ngml–1; R&D
Systems), Pam3CSK4 (1mgml–1; Invivogen, San Diego, CA), lipoteichoic
acid (10mgml–1; Sigma-Aldrich), poly(I:C) (10mgml–1; Invivogen),
lipopolysaccharide (1mgml–1; Sigma-Aldrich), flagellin (50ngml–1;
Alexis Biochemicals, Carlsbad, CA), MALP-2 (100ngml–1; Alexis
Biochemicals), imiquimod (10mgml–1; Invivogen), CL075 (5mgml–1;
Invivogen), or ODN M362 (10mgml–1; Invivogen) in 24-well flat bottom
plates (Corning Incorporated Life Sciences, Lowell, MA) for up to
96 hours. After cell stimulation, total cell media were stored at 20 1C
until analysis. RNA was extracted using TRIzol reagent (Invitrogen,
Carlsbad, CA) after supernatant collection. RNA was stored at 801C.
Quantitative real-time-PCR
Complementary DNA was synthesized from RNA by the iScript cDNA
Synthesis Kit (BioRad, Hercules, CA) as described by the manufacturer’s
protocol. TaqMan Gene Expression Assays (Applied Biosystems
ABI, Foster City, CA) were used to analyze expressions of human
KLK5 (assay ID: Hs00202752_m1), human KLK7 (assay ID:
Hs00192503_m1), human KRT10 (assay ID: Hs00166289_m1), human
IVL (assay ID: Hs00846307_s1) as described by the manufacturer’s
instructions (the user bulletin #2 by Applied Biosystems). GAPDH
mRNA was detected by probe: VIC-CATCCATGACAACTTTGGTA-
MGB; primers: 50-CTTAGCACCCCTGGCCAAG-30; and 50-TGGTCAT
GAGTCCTTCCACG-3, and was used as an internal control to validate
RNA for each sample. Each mRNA expression was calculated as the
relative expression toGAPDHmRNA, and all data are presented as fold
change against each control (mean of non-stimulated cells).
ELISA
KLK5 or KLK7 protein in NHEK cultured media was measured by ELISA.
96-well EIA plates (Corning) were coated with mouse monoclonal anti-
KLK5 or KLK7 antibody (1mgml–1 in phosphate-buffered saline (PBS),
catalog number: MAB1108 or MAB2624, respectively, R&D Systems) at
20–25 1C overnight. After washing with PBS containing 0.05% Tween
20 (washing buffer), the wells were blocked with PBS containing 1%
BSA for 1 hour at 20–25 1C. After incubation with the cultured media or
recombinant KLK5 or KLK7 (R&D Systems) as standards for 2 hours,
biotinylated goat anti-KLK5 or KLK7 antibody (0.1mgml–1, catalog
number: BAF1108 or BAF2624, respectively, R&D Systems) was used
as detection antibody. Streptoavidin-conjugated horseradish peroxidase
(R&D Systems) and 3,305,50-tetramethylbenzidine substrate (BD Bio-
sciences, San Jose, CA) were used for colorimetric quantification, and
reactions were stopped by 0.2M sulfuric acid (Sigma-Aldrich). The
absorbance at 450nm was monitored with SpectraMax Plus384
(Molecular Devices Corp., Sunnyvale, CA), and concentrations in the
samples were calibrated from the standard curve of recombinant KLK5
or KLK7 using SoftMax Pro4.6 (Molecular Devices Corp.).
In-cell western assay
KRT10 and IVL protein expression was examined by In-Cell Western
Assay (LI-COR Biosciences, Lincoln, NE). NHEKs were cultured in
96-well plates and stimulated with high calcium (2mM),
1,25(OH)2VD3 (10
–9 or 10–7 M), 9-cis RA (10–9 or 10–7 M), or 13-cis
RA (10–9 or 10–7 M) for 24 or 48 hours. After the media were removed,
cells were fixed with 3.7% paraformaldehyde for 20 minutes at room
temperature (20–25 1C), permeabilized by 0.1% Triton X-100 contain-
ing PBS. Mouse monoclonal anti-IVL antibody (clone SY5, Sigma-
Aldrich) or rabbit polyclonal anti-KRT10 antibody (Covance, Emery-
ville, CA) was used for primary antibodies, and IRDye 800CW-labeled
secondary antibodies were used to detect the signals. Cells were
counterstained with DRAQ5 and Sapphire700 by following the
manufacturer’s instructions. The signals from IRDye 800CW were
normalized by the signals from DRAQ5 and Sapphire700, and the %
response was calculated each time against vehicle-treated control as
100%. The data represent means and SEM in graphs.
Immunostaining
For immunocytofluorescence, NHEKs were grown on chamber slides.
Cells were stimulated with 1,25(OH)2VD3 for 24 hours. After removing
the culture media, cells were fixed with 4% paraformaldehyde, blocked
with 3% BSA in PBS, and incubated with mouse monoclonal anti-KLK5
antibody or anti-KLK7 antibody and rabbit anti-LL-37 antibody at 4 1C
overnight. After washing with PBS, FITC-conjugated goat anti-rabbit IgG
antibody (Jackson Immuno Research Laboratories, West Grove, PA) and
AlexaFluor568-conjugated goat anti-mouse IgG antibody (Molecular
Probes/Invitrogen, Eugene, OR) were used as the second antibody.
Sections were mounted in the ProLong Gold Anti-Fade reagent with
DAPI (Molecular Probes/Invitrogen). Images were obtained by Zeiss
LSM700 laser scanning confocal microscope (Carl Zeiss MicroImaging,
Thornwood, NY) or by Olympus BX41 fluorescent microscope
(Scientific Instrument Company, Temecula, CA).
Protease assay
Protease activity in cultured media was monitored with EnzChek
Protease Assay Kit green fluorescence (Molecular Probes/Invitrogen)
according to the manufacturer’s instructions. Briefly, 100ml of the
cultured media was mixed with 100 ml of BODIPY FL casein
substrate in 10mM Tris-HCl, pH 7.8, and incubated at 37 1C for
48 hours. Protease activity was monitored as increased fluorescence
with SpectraMax GEMINI EM (Molecular Devices Corp.).
SELDI-TOF-MS
NHEKs were stimulated with 1,25(OH)2VD3 (10
–7 M) or Ca2þ (1mM)
for 48 hours. Cells were dissolved in 100ml of radioimmunopreci-
pitation assay (RIPA) buffer (50mM HEPES, 150mM NaCl, 0.05%
SDS, 0.25% deoxycholate, and 0.5% NP-40; pH 7.4) containing
protease inhibitors (Roche Applied Science, Indianapolis, IN).
Samples were sonicated for 3 minutes and centrifuged for 10
minutes at 12,000 g. We transferred the supernatant to new tubes
and kept it at 20 1C until SELDI-TOF-MS analysis. Protein chips
(RS-100 protein chip array; Ciphergen Biosystems, Fremont, CA)
were coated with 4ml of rabbit antibody to LL-37 for 2 hours at room
temperature, and then blocked with 0.5 M ethanolamine in PBS (pH
8.0). After three washes with 0.5% Triton-X in PBS, protein chips
were assembled in the Bioprocessor reservoir, 50 ml of eluted sample
was applied, and the chips were incubated for 2 hours at room
temperature. The protein chips were washed twice with RIPA buffer,
once with PBS containing 0.5% Triton-X and three times with PBS,
and then soaked in 10mM HEPES buffer and air-dried. We applied
0.5 ml of the energy absorbance molecule (50% saturated a-cyano-4-
hydroxy cinnamic acid in 50% acetonitrile plus 0.5% trifluoric acid)
twice, and all spots were allowed to dry completely. Samples were
analyzed on a surface-enhanced laser desorption/ionization mass
analyzer PBS II with a linear time-of-flight mass spectrometer
(Ciphergen Biosystems) using time-lag focusing. Synthetic LL-37
peptide was used as reference to calibrate the exact mass sizes.
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Statistics
Results are expressed as the mean±SEM. Student’s t-test was used to
determine significance. Po0.05 was considered significant.
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